The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab

SIMPLE SUMMARY: Non-resectable biliary tract cancer is incurable. The balance between last-line treatment, with limited improvement in survival, and potential adverse events calls for prognostic biomarkers aiding the decision making process. The aim of this retrospective study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Line Bechsgaard, Mahler, Marit Sofie Kjær, Andersen, Rikke Fredslund, Jensen, Lars Henrik, Raunkilde, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558975/
https://www.ncbi.nlm.nih.gov/pubmed/36230519
http://dx.doi.org/10.3390/cancers14194598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558975/
https://www.ncbi.nlm.nih.gov/pubmed/36230519
http://dx.doi.org/10.3390/cancers14194598

Ejemplares similares